Funding Opportunities

• Implementation of shared decision making for HLBS diseases and conditions (R01 Clinical Trial Optional)
  (PA-19-166)
  National Heart, Lung, and Blood Institute
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 5, 2019.
• Development and Validation of Advanced Mammalian Models for Alzheimers Disease-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed)
  (PAR-19-167)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): March 14, 2019.
• Biology of Bladder Cancer (R01 Clinical Trial Optional)
  (PAR-19-168)
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 5, 2019. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Biology of Bladder Cancer (R21 Clinical Trial Optional)
  (PAR-19-169)
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 16, 2019. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Progression Markers for Cognitive Impairment in Parkinson's Disease Dementia (R01 Clinical Trial Not Allowed)
  (PAR-19-170)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): March 8, 2019 apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Mechanistic studies on chronic alcohol use and sleep homeostasis (R01 Clinical Trial Optional)
  (RFA-AA-19-006)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): April 17, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement
• HIV/AIDS Clinical Trials Networks Laboratory Centers (UM1 Clinical Trial Required)
  (RFA-AI-19-001)
  National Institute of Allergy and Infectious Diseases
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Only accepting applications for the AIDS application Due Date listed below.
• HIV/AIDS Clinical Trials Networks Statistical and Data Management Centers (SDMC) (UM1 Clinical Trial Required)
  (RFA-AI-19-002)
  National Institute of Allergy and Infectious Diseases
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Only accepting applications for the AIDS application Due Date listed below.
• HIV/AIDS Adult Therapeutics Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)
  (RFA-AI-19-003)
  National Institute of Allergy and Infectious Diseases
  National Institute on Drug Abuse
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Only accepting applications for the AIDS application Due Date listed below.
• HIV/AIDS Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)
  (RFA-AI-19-004)
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date listed below.
• HIV Prevention Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)
  (RFA-AI-19-005)
  National Institute of Allergy and Infectious Diseases
  National Institute on Drug Abuse
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date listed below.
• HIV Vaccines Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)
  (RFA-AI-19-006)
  National Institute of Allergy and Infectious Diseases
  National Institute of Dental and Craniofacial Research
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date listed below.
• Natural Products NMR Open Data Exchange (NP-NODE) (U24 Clinical Trial Not Allowed)
  (RFA-AT-19-002)
  National Center for Complementary and Integrative Health
  Office of Dietary Supplements
  Application Receipt Date(s): April 1, 2019), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Center for Natural Product Technology, Methodology, and Productivity Optimization (NP-TEMPO) (U41 Clinical Trial Not Allowed)
  (RFA-AT-19-003)
  National Center for Complementary and Integrative Health
  Office of Dietary Supplements
  Application Receipt Date(s): April 29, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)
  (RFA-CA-19-032)
  National Cancer Institute
  Application Receipt Date(s): August 1, 2019; August 3, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Establishing a Cohort to Clarify Risk and Protective Factors for Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) - Planning Cooperative Agreements (U34 Clinical Trial Not Allowed)
  (RFA-DK-18-007)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): April 11, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Obesity Research (U01 Clinical Trial Not Allowed)
  (RFA-DK-19-001)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): April 17, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates No late applications will be accepted for this Funding Opportunity Announcement.
• NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)
  (RFA-HL-20-011)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): March 14, 2019; February 14, 2020; February 15, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)
  (RFA-HL-20-012)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): March 14, 2019; February 14, 2020; February 15, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Limited Competition for a Connectome Coordination Facility (R24 Clinical Trial Not Allowed)
  (RFA-MH-20-210)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): June 24, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement
• Botanical Dietary Supplements Research Centers (U19 Clinical Trial Optional)
  (RFA-OD-19-001)
  Office of Dietary Supplements
  National Institute on Aging
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): April 15, 2019), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.